Katarzyna Olszewska-Turek

Dr. Katarzyna Olszewska-Turek

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 November 2022 in Healthcare
Verified
Journal Article
Open access
PDF file
KOKatarzyna Olszewska-Turek
Katarzyna Olszewska-Turek
BBBarbara Bętkowska-Korpała
Barbara Bętkowska-Korpała
Quality of life is an important factor influencing mood. In any group of elderly people undergoing valve implementation or surgical aortic valve replacement, one in three will have depressive symptoms. The aims of this study were as follows: 1. to evaluate the impact of health-related quality of life on depressive symptoms in elderly patients undergoing TAVI, and 2. to analyze beliefs about TAVI. Methods: A total of 131 elderly people (mean age: 82.1 ± 6.1 years) scheduled to receive TAVI completed the Geriatric Depression Scale, EQ-5D-3L, and Mini Mental State Examination. A total of 43 patients completed the questionnaires after the treatment. The narrative interview analyses were performed based on 20 randomly selected patients after TAVI. Results: The mean level of general depression before TAVI was 4.19 ± 2.83, and after it was 3.12 ± 2.52 (p = 0.02), and the frequency decreased from 20% to 3%. An increase in the level of activity and number of interests and a decrease in life satisfaction were identified. The higher the general quality of life was, the lower the levels of depressiveness before and after TAVI were (r = 0.26 vs. r = 0.48; p < 0.05). Conclusions: Patients differed in their depressive symptoms, as well as their intensity and frequency, before and after TAVI. These results underscore the importance of screening for depression at baseline and reassessing changes in depressiveness during follow-up.

1 January 2021 in Journal of Stomatology
Verified
Journal Article
Open access
PDF file
ZJZofia Juszka
Zofia Juszka
WMWojciech Marchewka
Wojciech Marchewka
ASAleksandra Smolana
Aleksandra Smolana
KSKatarzyna Szczeklik
Katarzyna Szczeklik
KOKatarzyna Olszewska-Turek
Katarzyna Olszewska-Turek
JLJolanta E. Loster
Jolanta E. Loster
Introduction Dental students are extremely stressed-out group of young people. Objectives: The aim of our study was to evaluate factors inducing most of the stress and identify students who are most susceptible to it. Material and methods A survey was carried out during a winter exam...

13 August 2024 in Psychiatria i Psychologia Kliniczna
Verified
Journal Article
Open access
PDF file
KOKatarzyna Olszewska-Turek
Katarzyna Olszewska-Turek
ALAnna Laskowska-Wronarowicz
Anna Laskowska-Wronarowicz
APAnna Pastuszak-Draxler
Anna Pastuszak-Draxler
ASAnna Starowicz-Filip
Anna Starowicz-Filip
JWJolanta Walczewska
Jolanta Walczewska
BBBarbara Bętkowska-Korpała
Barbara Bętkowska-Korpała
Introduction and objective: Both the illness itself and hospitalisation due to COVID-19 are potentially traumatic experiences, especially when the course of the disease is severe. Resilience has been identified as a crucial factor in the process of successfully coping with traumatic events and may protect against the development of symptoms of post-traumatic stress disorder. The aim of this study was to determine the role of resilience in the prevention of post-traumatic stress disorder symptoms in patients requiring hospitalisation due to COVID-19. Materials and methods: A total of 138 patients (59 women, 79 men; mean age: 52.34 years; standard deviation, SD = 12.46) hospitalised at the University Hospital in Krakow were included in the study, which was conducted 7–8 months after their COVID-19 diagnosis. The PTSD Checklist for DSM-5 (PCL-5) and the Resilience Measurement Scale (SPP-25) were administered, and stepwise multiple regression analysis was used in the predictive models. Results: A total of 31 participants (22.5%) met the criteria for probable post-traumatic stress disorder symptoms. The study participants were characterised by a moderate level of resilience (5th sten), with women exhibiting lower levels than men. Higher levels of resilience were associated with lower severity of PTSD symptoms. A significant predictor of post-traumatic stress disorder symptoms was “Tolerance for failure and treating life as a challenge”. Conclusions: Resilience has an impact on the severity of symptoms of post-traumatic stress disorder. Specifically, the dimension of “Tolerance” within resilience appears to be an important protective factor against post-traumatic stress disorder symptoms after hospitalisation for COVID-19. Patients hospitalised with severe course of COVID-19 exhibit a moderate level of resilience, with men demonstrating higher resilience levels than women.

13 August 2024 in Psychiatria i Psychologia Kliniczna
Verified
Journal Article
Open access
PDF file
ALAnna Laskowska-Wronarowicz
Anna Laskowska-Wronarowicz
KOKatarzyna Olszewska-Turek
Katarzyna Olszewska-Turek
AMAgnieszka Micek
Agnieszka Micek
BBBarbara Bętkowska-Korpała
Barbara Bętkowska-Korpała
Introduction: The severity of depression symptoms in COVID-19 patients differs among populations investigated and changes over time. Increasing evidence supports the hypothesis about the involvement of inflammation in the development of depression. Methods: A systematic review and a meta-analysis of the cross-sectional and cohort studies published between 2019 and 2023 were conducted according to the PRISMA criteria. The outcomes of interest were the proportions of mild, moderate, and severe depression symptoms during and after hospitalisation, and associations between depression and inflammation in COVID-19 patients. Results: Thirty articles were included in the systematic review. In the quantitative meta-analysis, the overall proportions of moderate-to-severe and mild-to-severe depression were estimated at 0.21 (95% CI: 0.13–0.31) and 0.35 (95% CI: 0.23–0.48), respectively. The fixed effects model of the meta-analysis of inflammatory markers showed a difference between COVID-19 patients with and without depression, with higher concentrations of both C-reactive protein and neutrophil-lymphocyte ratio detected among people suffering mood disturbances. However, in random effects models, findings for C-reactive protein lost significance, and for neutrophil-lymphocyte ratio were on the boundary of significance (p = 0.053). Conclusions: According to the study results, the proportion of depression decreases over time after a COVID-19 diagnosis. The relationship between depression and inflammation is still uncertain and requires further research.


30 June 2025 in Psychiatria Polska
Verified
Journal Article
Open access
BBBarbara Bętkowska-Korpała
Barbara Bętkowska-Korpała
KOKatarzyna Olszewska-Turek
Katarzyna Olszewska-Turek
APAnna Pastuszak-Draxler
Anna Pastuszak-Draxler
ALAnna Laskowska-Wronarowicz
Anna Laskowska-Wronarowicz
JWJolanta Walczewska
Jolanta Walczewska
DDDominika Dudek
Dominika Dudek
Cel pracy: Celem badania było ustalenie współwystępowania objawów psychopatologicznych i predyspozycji osobowościowych w zespole stresu pourazowego (PTSD) i jego wymiarów kilka miesięcy po hospitalizacji pacjentów z ciężkim COVID-19 w okresie 2 i 3 fali epidemii.Metoda: Badanie przeprowadzono w grupie 138 osób, w okresie 7-8 miesięcy po hospitalizacji z powodu Covid-19. Badani wypełniali kwestionariusze PCL-5 i TIPI oraz skale HADS i AIS. W modelach zastosowano analizę korelacji oraz analizę krokowej regresji wielokrotnej, w których zmiennymi niezależnymi były: stres, lęk, depresja i zaburzenia snu a zależnymi PTSD i jego wymiary.Wyniki: 22,5% pacjentów spełniło kryteria PTSD. Kobiety i mężczyźni nie różnili się pod względem nasilenia lęku, depresji, zaburzeń snu, dystresu oraz PTSD. Z nasileniem PTSD współwystępowały: lęk, zaburzenia snu, depresja. Wszystkie wymiary PTSD były powiązane z lękiem. Intruzja i Zmiany w pobudzeniu i reaktywności były powiązane z zaburzeniami snu. Zmiany w pobudzeniu i reaktywności były powiązane z subiektywną oceną dystresu. Negatywnych zmiany w funkcjonowaniu poznawczym i nastroju były powiązane z depresją oraz niskim poziom ekstrawersji.Wnioski: Istnieje współwystępowanie nasilenia objawów psychopatologicznych takich jak lęk, depresja, dystres i zaburzenia snu z nasileniem PTDS i jego wymiarów wśród pacjentów, którzy przeszli w nieodległej przeszłości ciężkie zachorowanie na Covid-19. Czynnikiem chroniącym przed PTSD po hospitalizacji jest wyższy poziom ekstrawersji. Obecność nasilenia stresu oraz któregokolwiek z badanych objawów obserwowanych u Pacjenta w trakcie kontrolnej wizyty lekarskiej sugeruje konieczność pogłębienia diagnozy w kierunku szerszego wymiaru trudności w postaci PTSD u chorych, którzy byli hospitalizowani z powodu COVID-19 i wdrożenia specjalistycznej psychiatryczno-psychologicznej pomocy.